About Thylacine Biotherapeutics
Thylacine Biotherapeutics is a private company based in Miami Beach, Florida, incorporated in 2021 in Delaware. It has reported $476,000 raised in one offering on Form D since January 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 5, 2023 | Jan 19, 2023 | $476,000of $1.0M target | 13 | $36,615 | Equity, DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Thylacine Biotherapeutics's Form D filed Jan 19, 2023.
RG
Robert Graifman
Director
DG
Daniel Graifman
Executive officer and director
AF
Andrew Fradkin
Secretary and General Counsel, director